Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 918 of 1,261
  1. US 8207142

    Inhibitor of DNA methylation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  2. US 8206715

    Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  3. US 8202538

    Orally disintegrating layered compositions

    Capricorn Pharma Inc. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  4. US 8202517

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  5. US 8202520

    Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  6. US 8202242

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  7. US 8202549

    Mesocellular oxide foams as hemostatic compositions and methods of use

    The Regents of the University of California · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  8. US 8202844

    Indole antiviral compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  9. US 8202861

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  10. US 8202889

    Inhibitors of bacterial IMPDH

    Vertex Pharmaceuticals Incorporated · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  11. US 8203005

    Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren

    Carbo Design LLC · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  12. US 8203030

    Transgenic mouse models for diseases caused by mtDNA mutations and related methods

    The Regents of the University of California · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  13. US 8202902

    Bivalent SMAC mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  14. US 8202891

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  15. US 8202980

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  16. US 8202893

    Cannabinergic lipid ligands

    UNIVERSITY OF CONNECTICUT · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  17. US 8202534

    Attachment of a handle to a solid oral dosage form

    TEVA WOMEN'S HEALTH, INC. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  18. US 8202551

    Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  19. US 8202507

    Assay for vitamin B12 absorption and method of making labeled vitamin B12

    The Regents of the University of California · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  20. US 8202990

    Polo-like kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  21. US 8202848

    Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration

    The Board of Regents of the University of Texas System · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  22. US 8197818

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  23. US 8198469

    Crystalline forms of tigecycline and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  24. US 8198406

    Methods and compositions for inhibiting angiogenesis

    Northwestern University · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.